NCT00666588 2018-05-22Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 2 Completed52 enrolled 17 charts